4
Changes in Ownership
TriSalus Life Sciences, Inc. Filed Acc 0001970009-25-000004
Chief Financial Officer acquired 65,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Patience David Chief Financial Officer | 2025-11-24 | Grant or award | +65,000 | 265,000 | D | ||
| Derivatives | |||||||
| Patience David Chief Financial Officer | 2025-11-24 | Grant or award · Employee Stock Option (right to buy) | +130,000 | 668,899 | D | ||
Loading xslF345X05/wk-form4_1764103242.xml…